ATC codes: P01CB01
Cutaneous leishmaniasis ICD11 code: 1F54.1
Medicine type
Chemical agent
List type
Core (EML)
Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule
EML status history
First added in 1987 (TRS 770)
Changed in 1989 (TRS 796)
Changed in 2002 (TRS 914)
Changed in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Changed in 2023 (TRS 1049)
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the listing for sodium stibogluconate / meglumine antimoniate on the EML and EMLc be amended to list each medicine separately with updated dosage form descriptions as follows: Sodium stibogluconate: Injection: 100 mg/mL in 30 mL vial Meglumine antimoniate: Injection: 1.5 g/5 mL in 5 mL ampoule